Human Immunodeficiency Virus Type 1 (HIV-1) gp120-directed Attachment Inhibitors

All categories

DBCAT005685Pharmacologic class

Agents that inhibit HIV-1 envelope glycoprotein gp120. A DrugBank category of 1 drug. 1 of them is approved.

Drugs: Fostemsavir

What you can answer from here — as of November 29, 2022

1DrugEach linked to its full drug card

Listed above

1Drug targetEvery drug–target pair in the class, with bond type

6Marketed productsAcross the regions we cover, with dosage forms and routes

1Route of administrationHow the drugs in this class are given

Which targets do Human Immunodeficiency Virus Type 1 (HIV-1) gp120-directed Attachment Inhibitors share, and which companies have late-stage candidates in this class?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account